Calvin Scott Recalls Diethylpropion Tablets Due to Missing Stability Studies
Calvin Scott & Company is recalling specific lots of Diethylpropion 75 mg tablets because they were repackaged without supporting stability studies.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is a cMGP deviation (missing stability studies) which is a quality control issue rather than a direct, reported physical hazard like a high-risk pathogen or structural defect.
Plain-English summary
Calvin Scott & Company, Inc. is recalling specific lots of Diethylpropion 75 mg tablets, NDC 00527-1477-01. The recall was initiated because the drug products were repackaged into pouches without supporting stability studies. This is a Class II recall, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The affected products were distributed to 12 physician consignees located in California, Idaho, Illinois, Oklahoma, and Rhode Island. The specific lot numbers involved are CS19192, CS19226, CS19263 (Exp 10/20), CS19300 (Exp 7/21), CS19338 (Exp 8/21), CS20034 (Exp 10/21), CS20077 (Exp 1/22), CS20165, and CS20241 (Exp 4/22).
Physicians and healthcare providers should stop using the affected lots and contact Calvin Scott & Company for further instructions. Patients who have received these specific lots should consult their healthcare provider regarding the recall.
The recalled product
- Product
- Diethylpropion, 75 mg tablets, Rx only, Distributed by: Calvin Scott & Co. Inc. Albuquerque, NM 87123; MFG. Lannett Company, Philadelphia, PA 19136, NDC 00527-1477-01
- Manufacturer
- Calvin Scott & Company, Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot #: CS19192
- CS19226
- CS19263
- Exp 10/20
- CS19300
- Exp 7/21
- CS19338
- Exp 8/21
- CS20034
- Exp 10/21
- CS20077
- Exp 1/22
- CS20165
- CS20241
- Exp 4/22
Distribution
Part of a larger recall action
This product is one of 3 recalled by Calvin Scott & Company, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Calvin Scott & Company, Inc.
See all →- SevereBenzonatate 100mg Capsules Label Mix-up — Wrong Medication in Bottles
FDA (Drugs) · 2022-06-01
- ModerateBenzphetamine tablets recalled due to label mix-up with Benzonatate
FDA (Drugs) · 2022-06-01
- ModerateCalvin Scott Recalls Phentermine Capsules Due to Stability Study Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Diethylpropion Tablets Due to Stability Deviations
FDA (Drugs) · 2020-10-14
- ModerateCalvin Scott Recalls Topiramate 25mg Tablets Due to Packaging Defect
FDA (Drugs) · 2020-08-26
Same hazard · quality control
See all →- ModerateApotex Recalls Paxil Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-02
- ModerateDuoGlide Short-Term Dialysis Catheter recall due to deficient manufacturing
FDA (Devices) · 2026-07-08
- ModeratedirectCHECK whole blood control labeled with incorrect performance range
FDA (Devices) · 2026-06-24
- HighAmyloid plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11
- HighpTau 217 plasma controls recalled over falsely elevated ratio results
FDA (Devices) · 2026-02-11